Cornell Research Foundation, Inc. v. Hewlett Packard Co.

223 F.R.D. 55, 2003 U.S. Dist. LEXIS 25810, 2003 WL 23712246
CourtDistrict Court, N.D. New York
DecidedDecember 9, 2003
DocketNo. CIV.A.5:01-CV-1974 (NAM/DEP)
StatusPublished
Cited by9 cases

This text of 223 F.R.D. 55 (Cornell Research Foundation, Inc. v. Hewlett Packard Co.) is published on Counsel Stack Legal Research, covering District Court, N.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cornell Research Foundation, Inc. v. Hewlett Packard Co., 223 F.R.D. 55, 2003 U.S. Dist. LEXIS 25810, 2003 WL 23712246 (N.D.N.Y. 2003).

Opinion

[57]*57 DECISION AND ORDER

PEEBLES, United States Magistrate Judge.

This is a patent infringement suit brought by plaintiffs Cornell University and its technology arm, the Cornell Research Foundation, Inc. (collectively “CRF”), against the Hewlet1>-Packard Company (“HP”), a preeminent manufacturer of electronic equipment and apparatus, including computer processors. At the heart of this action is a patent issued in 1989 and held by CRF, as assignee of the patent inventor, Hwa C. Torng, for a computer processor instruction issuing system and method. The issues in the case include the appropriate claim construction to be afforded to the patent at issue; its validity and enforceability; whether the patent was infringed by HP; and if so, what damages were suffered.

Currently pending before the court is a thorny discovery dispute consisting of several discrete components. Court intervention was first sought by CRF, which claims that HP has failed to produce materials falling in a variety of somewhat broad categories. For its part, HP has countered not only by asserting its good faith compliance with all outstanding discovery obligations, but additionally raising the issue of CRF’s own discovery shortcomings. As has been the case in all matters since inception of this litigation, the parties’ discovery dispute has been vigorously contested and resulted in the generation of extensive submissions to the court, obviously a function at least in part of the high stakes associated with the controversy.

I. BACKGROUND

On February 21, 1989 United States Patent No. 4,807,115 (the “’115 Patent”) issued to CRF, as assignee of Dr. Torng. Amended Complaint (Dkt. No. 43) H 6. The invention at issue in that patent relates to an instruction issuing system and method for processors with multiple functional units. Id. In simplistic terms, CRF contends that the methodology described in the ’115 patent allows for the non-sequential proceeding of instructions, thereby greatly enhancing the speed at which the device in which the processor is located operates.

According to CRF, HP has infringed the ’115 patent through the manufacture and/or sale of a line of processors, including those referred to by HP as its PA-8000 Series.1 Amended Complaint (Dkt. No. 43) 11119-11. Plaintiffs’ complaint also asserts the integration by HP of accused devices into its line of servers and work stations and, as will be seen, therefore seeks damages based upon the presence of the processors in those systems. Id. 1111. Plaintiffs’ complaint alleges direct, inducing and contributory infringement of the ’115 patent, and seeks a variety of relief including permanent injunction and damages. Id. “Wherefore” clause.

In its answer to the amended complaint, HP denies infringement and has asserted various affirmative defenses, including estop-pel, laches, in-equitable conduct, and patent exhaustion. Answer to Amended Complaint (Dkt. No. 47) HH 3-31. HP has also counterclaimed seeking declaratory relief including on the issue of non-infringement, patent invalidity, and patent unenforceability. Id. Counterclaim UK 1-15.

To place the current multifaceted and extremely complex discovery dispute in context, it is necessary to understand the nature of HP’s business as it relates to the accused products. Implicated in CRF’s claim of infringement of the ’115 patent is HP’s manufacture, as well as the manufacture for HP’s use by other companies, including International Business Machines (“IBM”), Intel Corporation (“Intel”) and potentially others, of microprocessors which are also sometimes referred to as central processing units (“CPUs”) or chips. Such processors have many functions and characteristics, among them being the manner in which instructions are ordered and processed — a matter which falls within the purview of the patent at [58]*58issue. A processor is one of many components comprising a “mother board”, which may be used in various computer hardware, including desktop computers and servers.

As noted, many of the accused devices are processors manufactured by HP, primarily though not necessarily exclusively for its use in other products such as HP servers and workstations.2 Some of the accused processors are manufactured for HP by other companies, including IBM and Intel. CRF acknowledges that Intel is a licensee under the section ’115 patent, giving rise to HP’s contention that it is shielded from liability by virtue of a patent exhaustion defense with regard to any processors manufactured by Intel and purchased by HP. There apparently is a question as to whether IBM is similarly licensed by CRF under the ’115 patent.

According to the parties’ presentations, HP does not sell processors. Instead, it sells other products, including servers and workstations, in both its name and, in certain eases, the name of other manufacturers, which in some instances may contain the accused processors as a component. As will be seen, it is the inclusion of the accused processors in other products that has led to a part of the instant discovery dispute.

II. PROCEDURAL HISTORY

CRF commenced this action on December 27, 2001. Dkt. No. 1. On August 30, 2002 an order was issued permitting plaintiffs to amend their complaint. Dkt. No. 41. An amended complaint was thereafter filed on behalf of CRF on September 6, 2002. Dkt. No. 43. HP responded to CRF’s amended complaint by the filing on September 19, 2002 of an answer, which includes counterclaims against CRF seeking declaratory relief, as previously noted. Dkt. No. 47. CRF has since answered plaintiffs counterclaim. Dkt. No. 52.

Following the commencement of suit, a pretrial conference was conducted pursuant to Rule 16 of the Federal Rules of Civil Procedure. At that conference it was determined that the discovery process in this case would be bifurcated, with the initial focus being upon matters relating to claim construction, and all other discovery to follow. A case management schedule was accordingly put in place allowing discovery to proceed with respect to the issues associated with claim construction, but precluding the parties from engaging in discovery with respect to all other issues until October 1, 2002. See Dkt. No. 11.

The case was the subject of a lengthy in-person claim construction hearing before District Judge Norman A. Mordue, beginning on April 29, 2003.3 Following that hearing, decision concerning the claims construction issue was reserved, and has not yet been issued.

The genesis of the pending discovery dispute was a letter from CRF’s counsel, Edward G. Poplawski, Esq., dated February 26, 2003 (Dkt. No. 164), requesting a conference with the court and outlining various areas of disagreement between the parties. That letter was met with a written response, dated March 3, 2003, from Stewart M. Brown, Esq., one of the attorneys for defendant HP (Dkt. No. 165), asserting that the parties had not yet conferred in good faith and reached impasse concerning the matters raised in Attorney Poplawski’s letter, and suggesting that such a course of action be taken prior to court intervention.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
223 F.R.D. 55, 2003 U.S. Dist. LEXIS 25810, 2003 WL 23712246, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cornell-research-foundation-inc-v-hewlett-packard-co-nynd-2003.